Frequently Asked Questions about Zeo ScientifiX, Inc. (ZEOX)

Name: Zeo ScientifiX, Inc. (ZEOX) Institutional Financial Dataset
Creator: Olyth
License: https://olyth.xyz

Question 1

What does Zeo ScientifiX, Inc. (ZEOX) do?

Accepted Answer

Zeo ScientifiX, Inc., a clinical-stage biopharmaceutical company, focuses on the development of biological therapeutics for the treatment of degenerative diseases and regenerative medicines. The company's lead product candidate is Zofin, an acellular biologic therapeutic derived from perinatal sourc...

Question 2

Is Zeo ScientifiX, Inc. (ZEOX) a good stock to buy?

Accepted Answer

Olyth's institutional analysis of ZEOX reveals an Altman Z-Score of -39.37 and a Piotroski F-Score of 3/9. These metrics, combined with its 5-year revenue trend ($0.01B most recent), help investors decide if ZEOX fits their risk profile.

Question 3

What is the current P/E ratio for ZEOX?

Accepted Answer

As of the latest trading session, Zeo ScientifiX, Inc. (ZEOX) has a trailing P/E ratio of -2.70.

Question 4

Who is the CEO of Zeo ScientifiX, Inc.?

Accepted Answer

The current Chief Executive Officer of Zeo ScientifiX, Inc. is Ian T. Bothwell.

Question 5

What was ZEOX's revenue for the last 5 years?

Accepted Answer

According to its latest income statements, Zeo ScientifiX, Inc. reported annual revenues of $0.01B (2025), $0.00B (2024), $0.00B (2023), $0.01B (2022), $0.01B (2021) respectively.

Question 6

Does ZEOX pay a dividend?

Accepted Answer

Zeo ScientifiX, Inc. does not currently pay a dividend to its shareholders.

Question 7

How much debt and cash flow does ZEOX have?

Accepted Answer

In its latest reporting period, Zeo ScientifiX, Inc. generated $-0.00B in Free Cash Flow against a total debt load of $0.00B.

Question 8

What is the Price-to-Book (P/B) ratio of Zeo ScientifiX, Inc.?

Accepted Answer

The Price-to-Book (P/B) ratio for Zeo ScientifiX, Inc. (ZEOX) is currently -36.21.

Question 9

What is the Price-to-Sales (P/S) ratio of ZEOX?

Accepted Answer

Based on trailing twelve-month data, Zeo ScientifiX, Inc. (ZEOX) trades at a Price-to-Sales (P/S) ratio of 2.34.

Question 10

What is Zeo ScientifiX, Inc.'s Return on Equity (ROE)?

Accepted Answer

Zeo ScientifiX, Inc. (ZEOX) has a Return on Equity (ROE) of 329.90%, representing its profitability relative to shareholder equity.